SLC22A3 and colorectal carcinoma: The results indicate significant enrichment in processes related to immune response, cell cycle regulation, apoptosis, and metabolic processes, suggesting that variations in SLC22A3 expression may impact critical cellular activities that contribute to CRC progression (Figure 9A).